Research Article
Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis
Table 2
Survival outcomes and relapses.
| | | Number | % |
| | Follow-up duration, months | | | | Median (range) | 13.3 (0.8–87.1) | | Overall survival (OS) | | | | Events/patients | 18/50 | | Median OS, months (95% CI) | 28.8 (18.3–39.1) | | 1-year OS, % (95% CI) | 87.6 (72.7–94.7) | | Progression-free survival (PFS) | | | | Events/patients | 33/50 | | Median PFS, months (95% CI) | 9.4 (7.7–13.9) | | 1-year PFS, % (95% CI) | 37.6 (22.7–52.5) | | Among relapsed patients | 32 | 100.0 | | Site of relapse | | | | Peritoneum | 28 | 87.5 | | Lymph nodes | 11 | 34.4 | | Lung | 15 | 46.9 | | Liver | 8 | 25.0 | | Bones | 5 | 15.6 | | Others | 8 | 25.0 |
|
|
CI, confidence interval.
|
